Takeda UK Limited
Unternehmen
Takeda is a patient-focused, values-based, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future to people worldwide. Our passion and pursuit of potentially life-changing treatments for patients are deeply rooted in over 230 years of distinguished history in Japan.
Adresse
Takeda UK Limited
1 Kingdom Street
London
W2 6BD
United Kingdom
Kontakt
Telefon für medizinische Informationen
+44 (0)3333 000181
Unternehmenswebseite
https://www.globalmedical.takeda.com/
E-Mail für medizinische Informationen
MedinfoEMEA@takeda.com
Unerwünschte Nebenwirkungen & Produktbeschwerden
Adverse Events in the UK should be reported through the Yellow Card Scheme. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Patients can report through the Yellow Card Scheme as well so don't need to consult a doctor first if reporting an Adverse Event.
To report an adverse event for a Takeda product, please contact: AE.GBR-IRL@takeda.com
If your query is regarding a product quality complaint for a Takeda product, please contact: Complaints.UK.Ireland@takeda.com
Please read our Website Privacy Policy before sending us any personal data via email.
Ein unerwünschtes Ereignis melden
AE.GBR-IRL@takeda.com
Company Website
https://www.takeda.com/en-gb/
Takeda Produkte
Arzneimittel, die mit einem▼gekennzeichnet sind, unterliegen einer zusätzlichen Überwachung. Dies ermöglicht eine schnelle Identifizierung neuer Sicherheitsinformationen. Sie können helfen, indem Sie mögliche Nebenwirkungen melden.
Adcetris ▼
(brentuximab vedotin)
ADVATE
(octocog alfa)
ADYNOVI ▼
(rurioctocog alfa pegol)
Alofisel ▼
(darvadstrocel)
Alunbrig ▼
(brigatinib)
CEPROTIN
(protein C)
Cinryze ▼
(C1-esterase inhibitor, human)
Cuvitru
(human normal immunoglobulin)
Edarbi
(azilsartan medoxomil potassium)
Elaprase ▼
(idursulfase)
Elvanse /-Adult
(lisdexamfetamine dimesylate)
Entyvio
(vedolizumab)
Equasym XL
(methylphenidate hydrochloride)
EXKIVITY ▼
(mobocertinib succinate)
FEIBA
(factor VIII inhibitor bypassing activity)
Firazyr
(icatibant acetate)
Fosrenol
(lanthanum carbonate hydrate)
GAMMAGARD S/D
(human normal immunoglobulin)
HyQvia
(human normal immunoglobulin)
Intuniv ▼
(guanfacine hydrochloride)
KIOVIG
(human immunoglobulin)
LIVTENCITY ▼
(maribavir)
Matrifen
(fentanyl)
Mepact
(mifamurtide)
Mezavant XL
(mesalazine)
Natpar ▼
(parathyroid hormone)
NINLARO
(ixazomib citrate)
OBIZUR ▼
(antihaemophilic factor, porcine factor viii:c, susoctocog alfa)
Plenadren
(hydrocortisone)
Prostap DCS
(leuprorelin acetate)
Prothromplex TOTAL
(human prothrombin complex)
Protium
(pantoprazole sodium)
Qdenga ▼
(dengue tetravalent vaccine (live, attenuated))
Reminyl
(galantamine hydrobromide)
Replagal
(agalsidase alfa)
Resolor
(prucalopride succinate)
Revestive ▼
(teduglutide)
RIXUBIS
(nonacog gamma)
TAKHZYRO
(lanadelumab)
VEYVONDI ▼
(vonicog alfa)
Vipdomet
(metformin hydrochloride, alogliptin benzoate)
Vipidia
(alogliptin benzoate)
VPRIV
(velaglucerase alfa)
Xagrid
(anagrelide hydrochloride)
